All about monoclonal antibody drugs — the experimental treatment that may have turned Trump’s COVID-19 around
Article content continued “It’s entirely possible that by the time you’re giving it, you’re giving it too late.” Medical technicians work at a drive-through COVID-19 testing facility at the Regeneron Pharmaceuticals company’s Westchester campus in Tarrytown, New York, September 17, 2020. Photo by Brendan McDermid/Reuters/File That Trump got something wholly experimental has raised eyebrows, but… Read More »
